On April 15, Xiamen Humanity Hospital was awarded as a “Collaborative Unit of Type 2 Inflammatory Skin Disease Clinical Research and Homogenized Diagnosis and Treatment Project in China” by the National Clinical Research Center for Dermatologic and Immunologic Diseases.

Type 2 inflammatory skin diseases are known to be a series of allergy-related diseases with type 2 inflammation as the mechanism of occurrence, and patients have a poor healing process, which seriously affects their physical and mental health. Xiamen Hongai Hospital will continue to improve its treatment and research capabilities, provide better treatment services for patients, and help to improve the treatment level of type 2 inflammatory skin diseases in China.